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Highlights: 
 
• The association between polysubstance use and inhibition is as-yet-unknown  
• This association was tested with a mega-analysis using individual participant data 
• Only lifetime cannabis use was associated with suboptimal inhibition (stop-task) 
• Lifetime cannabis use moderated tobacco’s effect on response inhibition 
• In cannabis non-users only, tobacco use was associated with suboptimal inhibition  
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Abstract 
Many studies have reported that heavy substance use is associated with impaired 
response inhibition. Studies typically focused on associations with a single substance, while 
polysubstance use is common. Further, most studies compared heavy users with light/non-
users, though substance use occurs along a continuum. The current mega-analysis accounted 
for these issues by aggregating individual data from 43 studies (3610 adult participants) that 
used the Go/No-Go (GNG) or Stop-signal task (SST) to assess inhibition among mostly 
“recreational” substance users (i.e., the rate of substance use disorders was low). Main and 
interaction effects of substance use, demographics, and task-characteristics were entered in a 
linear mixed model. Contrary to many studies and reviews in the field, we found that only 
lifetime cannabis use was associated with impaired response inhibition in the SST. An 
interaction effect was also observed: the relationship between tobacco use and response 
inhibition (in the SST) differed between cannabis users and non-users, with a negative 
association between tobacco use and inhibition in the cannabis non-users. In addition, 
participants’ age, education level, and some task characteristics influenced inhibition 
outcomes. Overall, we found limited support for impaired inhibition among substance users 
when controlling for demographics and task-characteristics. 
 
Keywords: 
Polysubstance use; Response inhibition; Stop-signal task; Go/No-Go task; Mega-analysis.  
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Introduction 
1.1.  Substance Use and Response Inhibition 
1.1.1. What is response inhibition and how does it relate to substance use? 
Inhibitory control, also known as response inhibition, has been defined as the ability 
to control one’s attention, behavior, thoughts, and/or emotions to override a strong internal 
predisposition or external lure, and instead do what is more appropriate or needed (Diamond, 
2013). Loss of control over one’s behavior is a defining characteristic of addiction. The 
DSM-5 lists characteristics such as ‘taking larger amounts or over a longer period than was 
intended’ and ‘unsuccessful efforts to cut down or control alcohol use’ to define the loss of 
control over drinking (American Psychiatric Association, 2013). Moreover, inhibitory control 
has been proposed to play an important role at different stages of the addiction cycle, i.e., 1) 
initial use of substance; 2) transition from recreational use to heavier use and abuse; 3) 
continuation of use for those who get addicted; 4) relapse after abstinence (e.g., Garavan, 
Potter, Brennan, & Foxe, 2015; Koob & Volkow, 2010). Furthermore, the dual process model 
on addiction proposes that an imbalance between a hyper-sensitized impulsive system, which 
is responsible for cue-reactivity, and a compromised reflective or control system (including 
inhibition of impulses) are important in the development of addiction (Bechara, 2005; 
Gladwin, Figner, Crone, & Wiers, 2011; Volkow, Fowler, Wang, & Swanson, 2004; Volkow, 
Koob, Mental, Parity, & Act, 2015). 
Over the past two decades, multiple studies have focused on the relationship between 
chronic substance use and response inhibition, but findings have been equivocal. Inhibitory 
impairment has been associated with chronic use of some substances (e.g., cocaine, ecstasy, 
methamphetamine, tobacco, and alcohol) but not for others (e.g., opioids, cannabis, see for a 
meta-analysis, Smith, Mattick, Jamadar, & Iredale, 2014). Results also vary in studies of 
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single substances. For instance, heavy drinkers have been reported to make more commission 
errors than light drinkers on the Go/No-Go task (GNG, Kreusch, Quertemont, Vilenne, & 
Hansenne, 2014), while alcohol-dependent and control participants did not differ significantly 
on the same measure (Kamarajan et al., 2005). Two main issues might explain these 
conflicting findings, namely the phenomenon of polysubstance use and the use of extreme 
group designs (i.e., comparing control participants and problematic or disordered substance 
users). In addition, sample demographics and task characteristics are often not taken into 
consideration. In order to address these issues in this mega-analysis, we aimed to investigate 
the relationship between inhibition and use of multiple substances by analyzing individual-
level data, while taking demographics and task characteristics into account. In doing so, we 
did not exclusively focus on populations diagnosed with substance use disorders (SUD, 
American Psychiatric Association, 2013). 
1.1.2. Experimental paradigms: the Go/No-Go task and the Stop-signal task  
Successful suppression of motor responses can involve distinct behavioral processes 
such as “action restraint” or “action cancellation” (Schachar et al., 2007). Action restraint 
refers to stopping a prepared but not yet initiated response, which is commonly measured 
using the GNG and its variants, such as Conners’ continuous performance task (Conners & 
Sitarenios, 2011; Donders, 1868/1969). These tasks focus on the ability to withhold 
responding if a no-go stimulus is presented. The main variables of interest are the rate of 
commission errors (i.e., failures to inhibit a response to no-go targets or false alarms), the rate 
of omission errors (i.e. failures to respond to go targets, or misses), and the response time (RT) 
to go stimuli. A relatively high rate of commission errors and a short go RT reflects 
suboptimal inhibition (Smith et al., 2014). 
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By contrast, action cancellation refers to stopping a response that is already underway. 
It is typically measured using the Stop-signal task (SST, Logan, 1994). In this paradigm, each 
trial starts with the presentation of a go signal that requires an overt response such as a button 
press. On a subset of trials (typically around 25%), the go signal is followed by a stop signal 
after a certain interval (stop-signal delay, SSD), upon which participants should inhibit their 
already initiated go response. Usually, an adaptive tracking algorithm controls the SSD, such 
that there is a 50% probability of inhibiting the response. A horse-race model, assuming an 
independent race between the ‘go’ and ‘stop’ processes, affords the estimation of the stop-
signal reaction time (SSRT, Logan, 1994). Given that the response could not be withheld on n 
percent of all stop trials (usually around at 50%), SSRT is calculated by subtracting the mean 
SSD from the go RT that marks the nth percentile in the go RT distribution.  
In contrast to the GNG, the latency of the go response and the latency of the stop 
process are considered to be independent (Logan & Cowan, 1984). Thus, a longer SSRT 
reflects an inhibitory deficit, whereas a longer go RT is interpreted as a lack of attention 
among other influencing factors (preparation, choice, and speed-accuracy trade-off, Lijffijt, 
Kenemans, Verbaten, & van Engeland, 2005).  
In addition to the GNG and the SST, other experimental paradigms, such as the 
Stroop (Stroop, 1992) and Eriksen Flanker tasks (Eriksen & Eriksen, 1974) have been 
proposed to measure inhibitory capacities. However, these paradigms measure distractor 
inhibition rather than motor response inhibition (Nigg, 2000; Ridderinkhof, van den 
Wildenberg, Segalowitz, & Carter, 2004). To keep the present review focused and allow for 
straightforward comparisons of results, we only included studies using the GNG and SST.  
 9 
 
1.2. Research Gaps and Research Needs  
1.2.1. Previous meta-analyses and reviews  
To date, there are at least nine published meta-analyses or review papers examining 
the relationship between inhibitory control and long-term substance use or behavioral 
addiction. In terms of scope, these studies can be classified into three categories. First, 
literature overviews focusing on a single substance (e.g., alcohol: Aragues, Jurado, Quinto, & 
Rubio, 2011; Stavro, Pelletier, & Potvin, 2013) or non-substance related disorder (e.g., 
gambling disorder: Chowdhury, Livesey, Blaszczynski, & Harris, 2017; Moccia et al., 2017). 
These reviews associated alcohol use with prolonged inhibition impairment, up to one month 
after abstinence (Stavro et al., 2013) and detoxified alcohol-dependent patients showed poor 
inhibition compared with healthy controls (Aragues et al., 2011). Polysubstance use was not 
systematically described or controlled for in either of the review studies on alcohol. 
Individuals with gambling disorder without comorbid SUD were reported to show large 
inhibition deficits (Chowdhury et al., 2017), which was attributed to impaired activity in 
prefrontal areas (Moccia et al., 2017). Second, other reviews focused on drawing general 
conclusions across multiple substances. For instance, Lipszyc and colleagues found that 
substance users generally did not differ significantly from controls in SST (Lipszyc & 
Schachar, 2010) and GNG performance (Wright, Lipszyc, Dupuis, Thayapararajah, & 
Schachar, 2014). However, such a review does not provide a clear profile for the effects of 
these substances in isolation or of specific interactions (i.e., greater than additive or 
compensation effects). A third category of literature reviews included multiple substances 
and the results were specified by the substance. Examples include a recent systematic review 
focused on neuroimaging findings (Luijten et al., 2014) and a meta-analysis focused on 
behavior (Smith et al., 2014). The latter meta-analysis indicated that inhibitory deficits were 
apparent for heavy use/disorders related to cocaine, ecstasy, methamphetamine, tobacco, 
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alcohol, and gambling but not for opioids or cannabis, without testing the interaction effect of 
using multiple substances (Smith et al., 2014). In sum, the current findings and conclusions of 
reviews and meta-analyses are rather inconsistent. If a conclusion can be drawn, it appears to 
be the counterintuitive conclusion that reviews and meta-analyses that focused on a specific 
addictive substance or behavior are more likely to report a significant association with 
inhibitory control compared to those reporting on multiple substance use. Importantly, none 
of these reports have considered several key variables that might bias the results, which will 
be highlighted in the next section.  
1.2.2. Important factors to consider 
1.2.2.1. Polysubstance use  
Polysubstance use broadly refers to the consumption of more than one drug over a 
defined period, either simultaneously or at different times (Connor, Gullo, White, & Kelly, 
2014; Subbaraman & Kerr, 2015). This involves different sub-categories, namely using 
different substances, the dependence of one substance and co-use of other substances or 
dependence on multiple substances. For instance, tobacco smoking is strongly associated 
with alcohol and marijuana use (Connor et al., 2014), opioids, and benzodiazepines are often 
prescribed simultaneously (Jones, Mogali, & Comer, 2012), and stimulants users are more 
likely to be heavy drinkers (McCabe, Knight, Teter, & Wechsler, 2005). Note that there is 
some evidence indicating that concurrent use of substances can lead to additionally toxic 
effects because of a toxic metabolite, as was reported for alcohol and cocaine (Pennings, 
Leccese, & Wolff, 2002). It is also possible that the use of one substance decreases the 
negative effect of another substance, as found with alcohol and cannabis (Schweinsburg, 
Schweinsburg, Nagel, Eyler, & Tapert, 2011). Hence, studying interactions between drugs on 
neurocognitive functions is important, given the frequent occurrence and possible interaction 
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effects. However, studies comparing substance users versus non-users or light users have 
typically focused on the primary substance of concern, while ignoring secondary substances. 
Up to now, only a few studies have investigated the relationship between polysubstance use 
and inhibition (Gamma, Brandeis, Brandeis, & Vollenweider, 2005; Moallem & Ray, 2012; 
Verdejo-García, Perales, & Pérez-García, 2007). Heavy drinking smokers did not show 
poorer SST response inhibition than smokers only and heavy drinkers only (Moallem & Ray, 
2012). Similarly, ecstasy polysubstance users did not show more strongly disturbed inhibitory 
brain mechanisms compared with controls (Gamma et al., 2005), and cocaine and heroin 
polysubstance users showed similar commission error rates as controls in the GNG (Verdejo-
García et al., 2007). A limitation of the latter two studies is that the greater-than-additive 
effect could not be examined without a group of single substance users. The lack of studies 
calls for a synthesis of research that does take polysubstance use into account.  
1.2.2.2. Substance use as a continuous variable  
All the above-mentioned reviews and meta-analyses included comparisons between a 
control or light user group and a heavy or problematic user group. Scores retained as a result 
of such extreme group designs are often coded and analyzed in terms of low versus high, 
reducing individual differences into a binary code. This practice involves ignoring individual-
differences of substance use in favor of creating quasi-arbitrary groups assumed to be 
homogeneous on the variable of interest (MacCallum, Zhang, Preacher, & Rucker, 2002; 
Royston, Altman, & Sauerbrei, 2006; Preacher, Rucker, MacCallum, & Nicewander, 2005). 
In the current study, we aimed to quantify substance use as a continuous variable.  
1.2.2.3. Abstinence  
Studies on long-lasting effects of substance use have generally been conducted by 
testing recently abstinent users. With respect to response inhibition, some studies have found 
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that abstinence from cocaine, methamphetamine and heroin normalized inhibitory function 
(Morie et al., 2014; Schulte et al., 2014), however, one study found sustained suboptimal 
performance after heroin abstinence (e.g., Fu et al., 2008). In addition, the duration of 
abstinence appears to moderate the return to normal functioning, which may explain these 
conflicting findings (Schulte et al., 2014). In order to preclude this as a confounder, we did 
not include studies on abstinence in (formerly) dependent users. All participants indicated 
substance use in everyday life, but were requested to refrain from using all substances (in 
most cases excluding tobacco) 24 hrs to one week before testing. 
1.2.2.4. Individual-level and task-level variables 
Some individual-level and task-level factors are known to affect inhibitory control and 
are therefore included in this mega-analysis, including the demographic variables age, sex, 
and education years. For GNG, six task parameters were controlled for: no-go percentage, 
number of experimental trials, working memory load (taxed or not), substance-related stimuli 
(used or not), cued GNG or not, and task complexity. For the SST, five task parameters were 
controlled for: number of experimental trials, stop-trial percentage, SSD settings, stop-signal 
modality, and SSRT calculation method. Reasons for controlling these confounders are based 
on a large primary literature on these tasks and are summarized in Supplementary Materials 
S1. Except for sex, for which the interaction with substance use was considered, all other 
factors were only controlled for regarding their main effect. 
1.3. Why a Mega-Analysis Rather Than a Meta-Analysis? 
A meta-analysis combines the summary statistics (i.e., effect sizes of included studies), 
while a mega-analysis combines the raw individual data from different studies. The latter 
method allows studying the combined effect of individual characteristics (cf. Price et al., 
2016) and examining the interaction effect of multiple substances used with enhanced 
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statistical power (Riley, Lambert, & Abo-Zaid, 2010). Therefore, we implemented a mega-
analysis with individual-level data.   
1.4.  The Goal of the Current Study 
Our primary goal was to examine the main and interaction effects of various kinds of 
long-term substance use on response inhibition. As the interaction effects of substance use on 
inhibition are rarely investigated and reported, we explore these interactions in the current 
study. We do so while controlling for demographics (e.g., age, sex, education years) and task-
related factors (e.g., no-go percentage, number of trials, whether stimuli are substance-related) 
that likely explain performance variance between studies and individuals. Interactions 
between substance use and sex were also included. Based on the literature reviewed above, 
we tested the following hypotheses: 1) According to Smith et al (2014) and other findings 
(Colzato, van den Wildenberg, & Hommel, 2007; Fillmore & Rush, 2002, Quednow et al., 
2007), we assumed that the inhibitory deficit would be more pronounced in users of  
psychostimulants (e.g., cocaine, ecstasy, methamphetamine, tobacco, and alcohol), especially 
for cocaine and amphetamines, given the known neuropsychopharmacology of the cortical 
and subcortical networks underlying impulse control (i.e., the right dorsolateral and inferior 
frontal cortices, Koob & Volkow, 2010; Smith, Mattick, Jamadar, & Iredale, 2014); 2) Given 
the literature, and as a validation of our individual-level mega-analysis, we expect some 
demographics (e.g., age and sex) and task characteristics (e.g., no-go percentage, whether 
stimuli are substance-related) to be associated with inhibition performance (see for expected 
directions of effects, Supplementary Materials S1).  
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2. Method 
2.1. Study Identification and Selection 
PsycINFO, Medline, EMBASE, Web of Science, CINAHL, and Cochrane Library 
were searched until 01/03/2016. Search terms and synonyms indicating substance use 
(alcohol, amphetamine, cocaine, cannabis, heroin, ketamine, methamphetamine, 
benzodiazepines, gambling, gamer, and internet addiction) were combined with terms 
indicative of inhibition (go/no-go, inhibitory control, inhibitory process, response inhibition, 
stop task, etc.). Published meta-analyses and reviews were also checked for additional studies 
(Horsley, Dingwall, & Sampson, 2011). Although behavioral addictions (e.g., gambling, 
internet addiction) were initially included, there were too few relevant studies to allow further 
analyses.  
2.1.1. Eligibility criteria  
The first author (YL) assessed the eligibility of all records using the following initial 
inclusion criteria: (a) presented in English; (b) conducted on human participants; (c) reported 
at least one measure from the following: no-go commission errors or go RT in the GNG; 
SSRT or go RT in the SST; (d) reported use of at least one kind of substance (e.g., alcohol, 
tobacco, cannabis, amphetamine, cocaine, ecstasy). Note that we included behavioral data 
from fMRI/EEG studies if available. In addition, we ran supplementary analyses to 
investigate whether inhibition performance varied with study type (behavioral/EEG/fMRI). It 
turned out that study type did not systematically influence behavioral performance (see 
Supplementary Materials S2). We excluded studies (a) that presented stop signals using a 
single SSD, as this is known to induce a performance strategy of delayed responding (Logan, 
1994); (b) in which the percentage of no-go or stop trials was higher than 50%, as this is 
known to invalidate the task (Nieuwenhuis, Yeung, & Cohen, 2004; Randall & Smith, 2011); 
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(c) that focused on the acute effects of substances on inhibition; (d) that recruited participants 
with a family history of substance dependence; (e) that excluded polysubstance users; (f) with 
participants that already received treatment for SUD or abstained from substance use; (g) 
with participants younger than 18. The exclusion of both intoxicated and abstinent consumers 
may have kept heavily affected/addicted participants from being included in the sample.  
After applying the inclusion and exclusion criteria by YL, a second rater (author YG)  
assessed the eligibility of a random subset (20%) of the records and obtained 100% 
agreement. Authors of eligible studies were invited via email to contribute raw data. 
Repeated attempts were made (i.e., four reminders were sent) if no response was received. 
Corresponding authors of the identified studies were asked to share their raw individual data, 
following our instructions on data requirements. The ‘essential variables’ included a set of 
pre-identified variables, including sociodemographic characteristics (e.g., age, sex, and 
education), typical alcohol and tobacco use (as alcohol and tobacco are two most commonly 
used substances), and task performance (Table S1a, S1b). ‘Optional variables’ 
(Supplementary Materials S3) included other demographic information recorded (e.g., race), 
other substance use (e.g., cocaine, cannabis) and questionnaires administered (e.g., Alcohol 
Use Disorder Identification Test (AUDIT), Saunders, Aasland, Babor, De la Fuente, & Grant, 
1993). The ‘optional variables’ were defined in a more flexible format with open questions. A 
study was included in our mega-analysis only if information about all ‘essential variables’ 
could be provided. 
2.1.2. Quality assessment and data extraction  
As the quality of included studies can influence mega-analysis in unpredictable ways 
(i.e., shortcomings in original studies will be carried over to the mega-analysis and thus 
weaken its conclusions, Müller, Brändle, Liechti, & Borgwardt, 2019), a quality assessment 
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of original studies was conducted. The methodological quality of studies was assessed by two 
authors (YL and YG) separately. We used the National Heart, Lung, and Blood Institute 
(NHLBI) Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies, 
which is widely used and recommended by Cochrane for quality assessment of observational 
and cross-sectional studies (Table S2, National Heart and Blood Institute, 2014). The total 
agreement (Good/ Fair/Suboptimal) between assessors was high (GNG: 20/24 = 83%, SST: 
16/20 = 80%). Inter-rater reliability, measured using Spearman's rank correlation coefficient 
was high for GNG (r = 0.84, p < 0.001) and moderate for SST (r = 0.56, p = 0.01, Kendall, 
1938). 
All provided data, including predictors (i.e., substance use, demographics, task 
characteristics) and dependent variables were merged into four datasets separated based on 
the four dependent variables (i.e., the commission error rate in GNG, go RT in GNG, SSRT 
in SST, and go RT in SST. As speed-accuracy trade-off is a potential issue in GNG (Zhao, 
Qian, Fu, & Maes, 2017), a balanced integration score was calculated (Liesefeld & Janczyk, 
2019). Main results applying this score as the outcome are presented in Supplementary 
Materials S4. The first author performed the data merging, which was verified by two authors 
(RW and WW).  
2.1.3. Publication bias check 
To examine whether significant findings in the original papers are indicative of 
evidential value, a p-curve was calculated and plotted (Simonsohn et al., 2015). In a p-curve, 
the x-axis represents p-values below 0.05, and the y-axis represents the percentage of studies 
yielding such a p-value. A right-skewed p-curve indicates evidential value, whereas a left-
skewed p-curve, many p-values just below 0.05,  may be indicative of flexibility in data 
analysis (Simonsohn et al., 2015). If the data did not indicate evidential value, a 33% power 
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test is performed to examine whether the absence of evidential value is due to insufficient 
power. A p-curve disclosure table was added in Supplementary Materials (Table S3) 
according to Simmons and Nelson (2015). P-curves and corresponding analyses were 
conducted using the p-curve app 4.06 (http://www.p-curve.com/app4, 2018). 
2.2. Individual Participant Data Meta-Analysis 
The analysis was conducted in the following steps: 1) apply additional exclusion 
criteria to the merged datasets; 2) standardize all continuous independent variables; 3) 
determine substance-related one-way variables; 4) dummy code all discrete variables; 5) 
determine and generate substance-related interaction variables; 6) multiple imputations of the 
missing values using all main and interaction variables; 7) build the linear mixed regression 
model with fixed effects of all predictors and a random intercept; 8) variable selection by 
stepwise backward elimination. These eight steps are outlined in more detail below.  
2.2.1. Construction of the database  
2.2.1.1. Individual and group exclusion criteria 
The data from the included studies were stacked into a single data file for each 
dependent variable, with unique identifiers for each study and for each participant. We 
further applied some minimal exclusion criteria to the individuals. That is, we excluded a 
participant if (1) he/she was younger than 18 years old; (2) he/she had missing data on all 
indices of substance use; (3) the dependent variable of current analysis (e.g., commission 
error rate) was missing; (4) SSRT was negative.  
A group of substance users from a certain study was excluded if the substance was not 
included as a predictor in the model. This happened when there was limited data provided for 
that substance (see criteria in 2.2.1.3.1.). For example, if it was concluded that opiate use was 
assessed insufficiently across all studies, we did not add opiate as a predictor. Consequently, 
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opiate users were excluded from the analysis. The excluded cases and groups from each study 
are listed in Table 1 and Table 2.  
2.2.1.2.  Standardization of independent variables 
2.2.1.2.1. Continuous variables  
Demographics like age and education level were transformed respectively into 
continuous variables years and years of education according to the education system in the 
country where the study was conducted. Task characteristics such as no-go percentage and 
number of trials in both tasks were also treated as continuous variables.  
Alcohol consumption was converted into the continuous variable grams of ethanol per 
month. Data on alcohol consumption were provided in two different ways. Most researchers 
provided data based on timeline follow-back (TLFB). These data were either already in 
grams per month or could be transformed by making use of standard drinks adjusted for 
country (Cooper, 1999). Some studies only had data from more general questionnaires. For 
instance, three studies (de Ruiter, Oosterlaan, Veltman, van den Brink, & Goudriaan, 2012; 
Luijten, O'Connor, Rossiter, Franken, & Hester, 2013; Rossiter, Thompson, & Hester, 2012) 
provided the raw data of the AUDIT (Saunders et al., 1993). In that case, we multiplied 
midpoints of item 1 (frequency), midpoints of item 2 (drinking days per month) and standard 
drinks in the country where the study took place. Similarly, four studies (Littel et al., 2012; 
Luijten et al., 2011; Luijten, Meerkerk, Franken, van de Wetering, & Schoenmakers, 2015; 
Luijten et al., 2013) provided Quantity Frequency Variability (QFV) score (Lemmens, Tan, 
& Knibbe, 1992). Again, items of quantity, frequency, and standard drinks were multiplied 
together. Smoking was coded as cigarettes per day. Two studies (Moallem & Ray, 2012; 
Rossiter et al., 2012) only had data from the Fagerström Test for Nicotine Dependence 
(FTND, Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991). In these cases, the midpoint 
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of the answer to item “How many cigarettes a day do you smoke” was used for daily cigarette 
use. One study used a self-developed 7-point Likert scale for the past 6 months tobacco 
consumption, for which we estimated daily cigarette use with the midpoint scores (Ames et 
al., 2014). Alcohol and tobacco use were standardized across the full dataset. All the other 
substance use variables had to be treated as dichotomous variables, as insufficient 
information was provided for treating it as a continuous variable in the model (see details 
below). 
2.2.1.2.2. Dichotomous variables 
For interpretability, dichotomous variables were effect-coded with value +1 or -1. 
Except for alcohol and tobacco use, other substances were coded as ‘lifetime use (yes = 1/no 
= -1)’.  
Four dummy task-characteristics were defined to classify the GNG studies: ‘working 
memory load (low/high)’, ‘substance-related (yes/no)’ ‘cued GNG (yes/no)’, and ‘task 
complexity (low/high)’. High working memory load, substance-related, cued GNG versions 
and complicated tasks were assigned the value of 1 (otherwise -1). Tasks with high working 
memory load were also assigned a value of 1 for task complexity as the association between 
stimuli and response was more complicated in these tasks.  
Similarly, for the SST, three dummy task characteristics were extracted, including 
‘stop-signal modality (visual/auditory)’, ‘SSD (fixed/staircase-tracking)’ and ‘SSRT 
calculation (integration/others)’. These variables were assigned a value of 1 if auditory stop 
signals were used; staircase-tracking procedure for SSD; and integration method for SSRT 
calculation (otherwise -1).  
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2.2.1.3.  Identification and generation of substance-related variables 
Except for alcohol use and tobacco use, other kinds of substances had missing data as 
not all studies provided information. Data provided varied in the level of detail, the way 
questions were asked, and the substances of main interest. For instance, depending on the 
primary substance of interest, some studies provided detailed information for cannabis use 
but no information on cocaine use (Bidwell et al., 2013), with an opposite pattern for others 
(Colzato, van den Wildenberg, & Hommel, 2007). In the following section, we explain the 
criteria for including substance-related variables in the model.  
2.2.1.3.1. One-way variables 
Due to missing data, a criterion was needed to include a variable in the model. We 
decided on a minimum of 100 participants per cell for a substance (which comes down to a 
power of 0.94 for the effect size of 0.5). As a result, final models for the GNG (both 
commission error rate and go RT) included cannabis, cocaine, amphetamine, ecstasy, and 
hallucinogens, in addition to alcohol and tobacco. For the SST (both SSRT and go RT), the 
final models included cannabis, cocaine, and ecstasy in addition to alcohol and tobacco.  
2.2.1.3.2. Two-way variables 
There were two types of two-way variables; the interaction of sex × substance and 
substance1 × substance2. Variables of sex × substance were created by multiplying sex with 
substance directly. For the second type, in order to evaluate whether there was sufficient data 
to assess these interactions, we again applied a criterion for inclusion. For example, dummy 
coding cannabis and cocaine use yielded a two by two table 
cannabis (yes/no) × cocaine (yes/no). The corresponding interaction was only entered into the 
model if all four cells had more than 20 entries. For alcohol and tobacco use, we 
dichotomized the data by a median split for table construction only. We performed an 
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additional analysis to test whether the number of substances used was a predictor of 
inhibition performance, and this was not the case (see Supplementary Materials S5). The list 
of included two-way variables can also be found in Supplementary Materials (Table S4a-
S4d). Demographics (in addition to sex) and task parameters could further moderate the 
relationship between substance use and inhibition. This, however, was not the focus of the 
current paper. In order to explore this potential issue, we analyzed interactions between 
alcohol on the one hand and demographics and task parameters on the other (see 
Supplementary Materials S6).   
2.2.1.3.3. Three-way variables 
Three-way variables were generated based on the substance1 × substance2 variables 
combined with sex. The corresponding variables were entered into the model only when all 
the eight cells in the three-way table 
sex (male/female) × substance1 (yes/no) × substance2 (yes/no) consisted of at least 10 entries. 
The list of three-way variables can be found in Supplementary Materials (Table S4a-4d).   
2.2.2. Missing data for independent variables and their interactions 
In the analysis of GNG commission error rate, the percentage of missing values 
ranged from 0 to 68.2% (highest: alcohol × hallucinogens × sex) and in the GNG go RT 
analysis, it ranged from 0 to 69.6% (highest: alcohol × hallucinogens × sex). For the SST, the 
percentage of missing values ranged from 0 to 84% for the SSRT 
(highest: tobacco × ecstasy × sex) and from 0 to 83.2% for the go RT (highest: 
tobacco × ecstasy × sex, a full list of missing data per variable can be found in Table S4a-
s4d).  
In order to deal with these missing data, we used multiple imputations (Rubin, 2004). 
The default imputation option in SPSS was chosen. It first scans the data and determines the 
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suitable method for imputation (Monotone or Fully Conditional Specification, FCS; Dong & 
Peng, 2013). All variables in the mixed regression model, including the main and interactive 
predictors and the dependent variable, were used for imputation. Apart from that, the discrete 
variable of ‘tobacco lifetime use’ was also used, as some studies assessed tobacco use 
dichotomously (smokers/non-smokers). It has been suggested that the number of imputations 
should be similar to the percentage of cases that are incomplete (White, Royston, & Wood, 
2011) and the precision improves by increasing the number of imputations (Bodner, 2008). 
Therefore, 100 complete data sets were generated, which were combined into a pooled result 
using the method proposed by Rubin (Rubin, 2004) and Schafer (Schafer, 1997).  
2.3. Statistical Analysis  
Backward elimination was used for variable selection. Initially, each imputed dataset 
was analyzed with a linear mixed model including all the above-mentioned main, second 
order, and third order effects as fixed effects and a random intercept (for which a model 
summary can be found in Tables S4a-S4d). We did not include random slopes and thus 
assumed that predictors had similar effects in each study. The fixed effects that were least 
significant (i.e., the one with the largest p-value) were removed and the model was refitted. 
Each subsequent step removed the least significant variable in the model until all remaining 
variables or its higher order variables had p-values smaller than 0.05 (Draper & Smith, 2014). 
For instance, if the variable alcohol × tobacco was significant, then variables of alcohol and 
tobacco would also be included in the model, irrespective of their independent significance.  
3. Results 
3.1. Study Selection 
3.1.1. Summary of authors’ responsiveness 
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Applying the inclusion and exclusion criteria resulted in a sample of 153 potentially 
eligible studies (Fig. 1). Out of these targeted papers, 4 researchers responded that they no 
longer had access to the datasets, 21 declined to participate, 52 did not respond to our 
invitation and 11 did not have all the basic information we asked for. In total, we obtained 
raw data from 65 studies. Out of these, 22 had to be excluded because the authors could not 
provide all the ‘essential variables’, such as data on monthly alcohol use in grams was 
unavailable (9 studies), missing data of tobacco use (5 studies), participants were abstaining 
from substance use (3 studies), participants were younger than 18 years old (2 studies), 
uncommon tasks were used (2 studies) and unsuitable outcome measures (1 study, provided 
stop latency instead of SSRT). The full list can be found in Supplementary Materials S7. The 
final dataset for the GNG comprised of 23 independent datasets from 24 papers (in some 
cases, more than one paper was published with the same dataset). For the SST, 19 datasets 
from 20 papers were included. In addition, one study administered both GNG and SST; 
therefore 43 unique studies were included in total.  
The final list of eligible studies was slightly different from the list of studies included 
in Smith and colleagues meta-analysis on summary statistics (Smith et al., 2014). For the 
GNG, there were 11 studies in common. For the SST, there were 6 studies in common. These 
discrepancies were related to different research questions. Since we aimed to assess the 
unique and combined effects of different substances, while Smith and colleagues focused on 
the unique effect of a single substance, some studies that were excluded by Smith and 
colleagues were included here and vice versa. In addition, individual data mega-analysis 
typically has a lower response rate compared to traditional meta-analysis, as it requires more 
work from the researchers (Riley et al., 2010; Riley, Simmonds, & Look, 2007).  
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3.1.2. Study description  
Table 1 and Table 2 present descriptive characteristics of the included GNG and SST 
studies before imputation, respectively.  
3.1.3. Findings in original studies  
For GNG, out of the 24 studies included, 9 (37.5%) reported that (heavy/problematic) 
substance users/excessive gamers made more commission errors than controls/light users (3 
for alcohol, 2 for tobacco, 1 for ecstasy, 1 for inhalant and 2 for excessive gamers), 1 (4.2%) 
reported opposite findings (i.e., opiate users made fewer commission errors compared to 
controls), 11 (45.8%) reported no significant differences (5 for alcohol, 2 for tobacco, 1 for 
ecstasy, 1 for inhalant and 2 for polysubstance use), and 3 (12.5%) didn’t have such an 
analysis (See Table 1 footnote). For the SST, out of the 20 studies, 5 (25%) reported 
substance users/gamblers had longer SSRT than controls (2 alcohol, 2 cocaine and 1 
pathological gambling), 1 (5%) reported the opposite direction (alcohol), 8 (40%) reported no 
difference (3 alcohol, 2 tobacco, 1 cannabis, 1 cocaine, and 1 pathological gambling) and 6 
(30%) did not provide such an analysis (see Table 2 footnote).  
3.2. Quality Assessment 
We rated the methodological quality of the studies according to the NHLBI 
assessment tool (see Tables 3a and 3b). For the GNG, most (58.3%) of the studies were of 
intermediate quality, 37.5% of high quality and 4.2% of suboptimal quality. For the SST, 40% 
of studies were of high quality and another 60% of intermediate quality. The main limitations 
were small sample size, especially for the studies focused on neuroimaging findings, and 
insufficient control of confounders such as the history of other kinds of drug use. For a few 
studies, the population was not fully described, lacking information of where and when the 
participants were recruited. To explore whether different study types differ in methodological 
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quality, we did a chi-square test based on Table 3. The results indicate that the percentages of 
studies of good, fair and suboptimal quality did not differ between behavioral (10/23, 13/23, 
0/23), EEG (4/8, 3/8, 1/8) and fMRI (3/12, 9/12, 0/12) studies (χ2 (4, N = 44) = 6.51, p = 
0.15). 
3.3. Publication Bias Check 
To examine evidential value in the original studies, a p-curve was created 
(Supplementary Materials Fig. S1). Out of the 31 effect sizes (unavailable for some studies), 
11 were statistically significant (p < 0.05), with 8 p < 0.025. The p-curve analysis on the 
association between substance use and response inhibition indicated no evidential value (full 
p-curve z = -0.98, p = 0.16; half p-curve z = 0.58, p = 0.72). However, this was likely due to a 
lack of power (33% power test, full p-curve z = -0.95, p = 0.17). 
3.4. Main Outcomes 
3.4.1. GNG: no-go commission errors 
None of the substance-related variables or their interactions had a significant effect on 
the commission error rate. Among all other variables, two demographic variables and three 
task characteristics significantly predicted commission error rates. Age significantly predicted 
commission error rate (β = -0.01, p < 0.01, 95% CI [-0.02, 0.00]), indicating that older 
participants showed decreased commission error rates. Education years also significantly 
predicted commission error rate (β = -0.01, p = 0.03, 95% CI [-0.02, 0.00]), indicating the 
higher the educational level, the lower the commission error rates. The nominal variable 
working memory load had a significant effect on commission error rate (β = 0.10, p < 0.01, 
95% CI [0.07, 0.14]), indicating that when working memory load was high, participants made 
more commission errors. The no-go percentage had a significant effect on commission error 
rate (β = -0.04, p < 0.01, 95% CI [-0.07, -0.02]), such that the higher the no-go percentage, 
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the lower the rate of commission errors. The number of trials also had a significant effect on 
commission error rate (β = 0.04, p < 0.01, 95% CI [0.02, 0.07]), indicating higher 
commission error rates when there were more trials.  
3.4.2. SST: SSRT 
Lifetime cannabis use significantly predicted SSRT, with users showing longer SSRT 
than non-users (β = 5.59, p = 0.03, 95% CI [0.41, 10.77]). Tobacco use was positively, 
although not significantly, associated with SSRT (β = 3.21, p = 0.06, 95% CI [-0.13, 6.55]), 
indicating that the more tobacco was consumed, the longer SSRT. The 
tobacco × cannabis interaction also had a significant effect on SSRT (β = -4.19, p = 0.03, 95% 
CI [-8.03, -0.37], Fig. 2). Post-hoc analyses were performed by splitting the imputed data sets 
and fitting the same restricted model without the interaction term. These analyses revealed 
that for the cannabis non-users, higher tobacco use was associated with longer SSRT (β = 
6.44, t = 2.70, p < 0.01). For cannabis users, no effect of tobacco use on SSRT was observed 
(β = -0.15, t = -0.05, p = 0.96). When split based on cigarette smoking (median-split of z-
score), the following effects were obtained: for low tobacco users, cannabis lifetime users did 
not differ significantly from cannabis non-users in SSRT (β = 7.62, t = 1.90, p = 0.06). A 
similar finding was observed among high tobacco users (β = 4.80, t = 1.74, p = 0.08).  
Education years also significantly predicted SSRT (β = -9.33, p < 0.01, 95% CI [-
12.88, -5.80]), indicating that the higher the education level, the shorter the SSRT. Age 
significantly predicted SSRT (β = 13.46, p < 0.01, 95% CI [9.29, 17.63]), with an increase in 
SSRT along with an increase in age. The number of trials also significantly predicted SSRT 
(β = -17.44, p < 0.01, 95% CI [-30.60, -4.28]), indicating a decrease in SSRT when there 
were more trials. In addition, stop-signal modality had an effect on SSRT (β = -28.58, p = 
0.01, 95% CI [-50.61, -6.56]), indicating that auditory stop signals induced shorter SSRT 
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compared to visual stop signals. SSD also had a significant effect on SSRT (β = -33.29, p = 
0.04, 95% CI [-64.61, -1.96]), indicating that the staircase-tracking procedure resulted in 
shorter SSRT compared to the fixed SSD procedure.  
For both SSRT and commission error rate, models including the interaction between 
alcohol use on the one hand and demographics and task parameters on the other resulted in 
largely comparable findings as presented here1. Only in the GNG, an interaction between 
alcohol use and age appeared (β = 0.01, p = 0.02, 95% CI [0.001, 0.02]). For light drinkers, 
older people made less commission errors (β = -0.02, t = -2.56, p = 0.01), which was in line 
with the main effect of age. Whereas for heavy drinkers, this relationship was absent (β = -
0.01, t = -1.50, p = 0.14). All other interactions with alcohol were found to be non-significant 
(Supplementary Materials S6). 
Outcomes for go RT in GNG and SST can be found in Supplementary Materials S8. 
Briefly, older people had longer go RT in both GNG and SST. Higher educated people had 
shorter go RT in SST. Although the interaction between cocaine and tobacco had an effect on 
go RT in SST, post-hoc analysis revealed no significant simple effect.  
4. Discussion 
Previous individual studies, reviews, and meta-analyses investigating inhibitory control 
deficits in relation to long-term substance use and SUD have provided mixed results (Luijten 
et al., 2014; Smith et al., 2014; Wright et al., 2014). These inconsistent findings might at least 
partly be due to insufficient control of frequently occurring polysubstance use. In addition, 
                                                          
1 In the model including interactions with demographics and task-parameters, tobacco and cannabis 
use were both positively associated with SSRT. However, their interaction was not significant, but the 
three-way interaction with sex was. Post-hoc tests indicated that, only for male non-cannabis users, 
tobacco use was positively associated with SSRT (see in Supplementary Materials S6). 
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studies differed in sample demographics and task-related variables and used extreme group 
designs. The current mega-analysis aggregated data of 3610 individuals, from 43 studies, in 
which polysubstance use, demographics, and task parameters were included in the prediction 
of inhibition performance by means of an imputed multilevel analysis. Most of the included 
studies were of medium to high quality, which validates the overall conclusions drawn. 
Surprisingly, our overall pattern of results indicated that most types of substance use did not 
show an association with response inhibition. While for most substances no effects were 
found, lifetime cannabis use was found to be associated with impaired inhibition, as indexed 
by an increased SSRT in the SST. Tobacco use was also associated with impaired inhibition 
as indexed by the same variable. In addition, an interaction between lifetime cannabis and 
tobacco use was found on SSRT, which indicated a strong positive relationship between daily 
tobacco use and SSRT in participants who did not use cannabis (indicating poorer inhibition), 
and the absences of such a relationship in users smoking cannabis. In addition, demographic 
factors such as age and years of education and task characteristics such as no-go percentage, 
affected inhibition performance in the expected direction, strengthening the credibility of the 
other results. 
4.1. Response Inhibition and Substance Use  
The main significant finding of our mega-analysis was that lifetime cannabis use was 
associated with prolonged response inhibition in the SST. One possible explanation is that 
this could (partly) involve subacute effects of cannabis use (i.e. lasting 7 hours to 4 weeks 
after last cannabis use, Gruber & Yurgelun-Todd, 2005; Pope & Yurgelun-Todd, 1996; 
Schulte et al., 2014). Acute cannabis use (i.e., 0-6 hours after last cannabis use) has been 
consistently reported to impair response inhibition in the SST (Metrik et al., 2012; Ramaekers 
et al., 2006). In contrast, findings of its long-term effect (i.e., 3 weeks or longer after last 
cannabis use) were mixed (Crean, Crane, & Mason, 2011), with some confirming an 
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impairing effect (Moreno et al., 2012), while others did not (Tapert et al., 2007). To have a 
closer look at the effect of cannabis, we compared cannabis daily users with less frequent 
users. A linear mixed regression model was built with the fixed effect of ‘cannabis daily users 
(yes/no)’ and a random intercept. It indicated that cannabis daily users did not differ from less 
frequent users on their stopping latency (i.e., SSRT., β = -6.42, p = 0.90, 95% CI [-114.27, 
127.10]), which does not support the hypothesis of subacute cannabis effects. Despite 
conflicting behavioral findings of the relationship between cannabis use and response 
inhibition, abnormalities in neural activation have often and more consistently been reported 
in relation to acute as well as chronic cannabis use compared with non-users (systematic 
review: Wrege et al., 2014). Age of onset may have a moderating effect on the neural effects 
of cannabis (Hester, Nestor, & Garavan, 2009), but we did not have sufficient data to test this 
hypothesis.  
In line with previous findings, tobacco use tended to impair inhibition. Participants with 
a higher level of tobacco dependence demonstrated a lower level of response inhibition 
capacities (Billieux et al., 2010), and smokers performed worse than non-smokers in a 
smoking-related GNG (Luijten et al., 2011). However, it should be noted that the main effect 
of tobacco use was qualified by a significant interaction with cannabis use, indicating a 
negative effect of tobacco use only in non-cannabis users. Another study reported that co-
administration of cannabis and tobacco attenuated the impairment in delayed recall memory 
caused by cannabis alone (Hindocha, Freeman, Xia, Shaban, & Curran, 2017), and other 
reports have indicated weaker impairment on some measures after polysubstance use (e.g., 
alcohol and cannabis, Schweinsburg et al., 2011). One possible interpretation of these 
findings is that cannabis has a protective effect when used together with other substances 
such as alcohol and tobacco (cf., Viveros, Marco, & File, 2006). Due to the high co-
occurrence of cannabis and tobacco use (Badiani et al., 2015; Leatherdale, Ahmed, & 
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Kaiserman, 2006), and the fact that concurrent tobacco use contributes to cannabis 
dependence symptoms (Ream, Benoit, Johnson, & Dunlap, 2008), further studies of the 
combined and single effects on response inhibition are warranted to elucidate these findings.  
What could explain the low evidence for a relationship between (most) long-term 
substance use and inhibition? On closer inspection, only 30% of studies included reported 
evidence for negative associations between substance use (or gambling) and response 
inhibition (Tables 1 and 2). In contrast, other studies reported evidence for positive 
associations between substance use and inhibition performance in GNG and SST (significant: 
Glass et al., 2009; nonsignificant: Galván, Poldrack, Baker, McGlennen, & London, 2011; 
Papachristou, Nederkoorn, Havermans, van der Horst, & Jansen, 2012; Vonmoos et al., 2013). 
In light of this, it is less surprising that the integrated results indicated overall largely null 
findings (most of the confidence intervals ranged around zero). Similarly, only one out of the 
five studies included in a recent review (Carbia, López-Caneda, Corral, & Cadaveira, 2018) 
reported impaired response inhibition—as measured by SST and GNG tasks—in binge 
drinkers compared with controls (Czapla et al., 2015). 
One explanation is that chronic recreational substance use without a diagnosis of SUD 
is not associated with response inhibition impairment. In other words, a threshold effect 
rather than a linear effect might exist between substance use and response inhibition 
performance. Alternatively, there might be a linear relationship, albeit shallow and we only 
see the effects when comparing very extreme groups (e.g., healthy controls vs. SUD in 
clinical samples). As a result of our exclusion criteria, Fig. S2a and S3a indicate that only a 
minority of the participants reached the level of SUD (either reported in individual paper or 
categorized based on questionnaire score), and most others were still within the normal range 
of use. It is conceivable that inhibition is only impaired in SUD (Bjork, Hommer, Grant, & 
Danube, 2004; Fernández-Serrano, Pérez-García, & Verdejo-García, 2011; Noël et al., 2007; 
 31 
 
Petit et al., 2014). Alternatively, inhibition problems may play a role in the transition from 
heavy use to SUD. In the SST sample, there were more people diagnosed with tobacco 
dependence (about 10%, Fig. S3a), which might explain why a positive (although not 
significant) association of SSRT and tobacco use was found. 
A second possibility is that substance use is actually associated with impaired 
inhibition, but we were unable to detect this. Possible reasons include: sample characteristics 
(as was discussed in the last paragraph), the type of tasks included, outcome measures (i.e., 
effects may only be visible in biological markers but not in behavior), and statistical power. 
Regarding tasks included, there is the possibility that (heavy) use of psychoactive substances 
does not lead to a general inhibition problem, but only to a specific problem in the domain of 
substance use (hence an interaction between an appetitive process and suboptimal control, 
Jones, Duckworth, Kersbergen, Clarke, & Field, 2018). A related explanation can be that 
self-control failures like maladaptive substance use may reflect a reduced mobilization of 
inhibitory control in substance-related contexts rather than generally impaired inhibitory 
control competencies (Krönke et al., 2018; Krönke, Wolff, Benz, & Goschke, 2015; Wolff et 
al., 2016). However, in a secondary analysis, we did not find that substance-related GNG 
moderated the relationship between alcohol and commission error rate (see details in 4.2.). 
Furthermore, the SST and GNG measure stimulus-driven (exogenous) inhibition, which may 
not closely match real-world ‘loss of control’ behavior related to substance use (e.g., an 
initial intention to have one drink escalating into a binge-drinking session, failed suppression 
of craving, etc). These examples reflect a different type of inhibition, namely endogenous or 
intentional rather than exogenous inhibition. Intentional inhibition paradigms such as the 
Marble task (Schel et al., 2014) could be considered in future research. Regarding outcome 
measures, it is possible that biological but not behavioral markers might be more sensitive to 
inhibition impairments among substance users (Garrison & Potenza, 2014). Relatedly, some 
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of the included MRI studies reported specific group-related abnormalities in brain activation 
but not in behavioral outcomes (e.g., Claus, Ewing, Filbey, & Hutchison, 2013; de Ruiter et 
al., 2012; Galván, Poldrack, Baker, McGlennen, & London, 2011; Karoly, Weiland, 
Sabbineni, & Hutchison, 2014; Luijten et al., 2013; Roberts & Garavan, 2010). In addition, a 
recent study indicated that resting state fMRI connectivity might serve as a promising 
biomarker of alcohol use disorder severity (Fede, Grodin, Dean, Diazgranados, & Momenan, 
2019; see further, Steele, Ding, & Ross, 2019 for additional recent approaches to identifying 
biormarkers for addiction). Alternatively, Kwako, Bickel, and Goldman (2018) suggested a 
dimensional approach to biomarkers in terms of executive functions (inhibitory control, 
working memory, etc.), which includes measuring neuropsychological tests and epigenetic 
changes in relevant genes (e.g., COMT). With respect to statistical power, polysubstance use 
was coarsely defined, such that substances other than alcohol and tobacco had to be coded in 
a binary lifetime use variable. It is still possible that (heavy) use of a specific combinations of 
substances at the same time (e.g., cocaine and alcohol, Schulte et al., 2014) does have a 
negative impact, which did not emerge from our analysis here using binary variables. In 
addition, the total author response rate was low, which we discuss as a limitation. Currently, 
it remains an open question whether substance use is not associated with a motor inhibition 
impairment or if we were incapable of detecting such an impairment. 
4.2. Demographics and Task Parameters 
Our results indicate that age is a significant predictor of performance. In the GNG-
task, the age-related increase in accuracy is most likely due to the strategic slowing of 
responses (confirmed by longer go RTs). In the SST, SSRT increased with age. Education 
was positively correlated with inhibition capability in both tasks. There was not a significant 
effect of sex on inhibition, nor any interactions between sex and substance use. In the GNG, 
higher working memory load, lower no-go percentages, and a higher number of experimental 
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trials resulted in more commission errors. These effects are in line with the primary literature 
on these tasks and are further discussed in Supplementary Materials S1. Somewhat 
surprisingly, we did not obtain an effect of substance-related GNG on performance measures 
compared to classical task versions. This is in line with a recent meta-analysis, where the 
main effect of appetitive cues was not observed after correction for publication bias, and 
where drinking status (light vs. heavy drinkers) also did not moderate this effect (Jones, 
Duckworth, Kersbergen, Clarke, & Field, 2018). In a small exploratory analysis, we 
examined the alcohol × substance-related task interaction effect, which was not a significant 
predictor of commission error rates in GNG (Supplementary Materials S6). Still, since our 
conclusion is based on only 5 out of 23 included studies, future research should address this 
question. In the SST, visual (vs. auditory) stop signals, fewer number of trials and fixed SSDs 
(vs. staircase-tracking procedure) induced prolonged SSRT (elaboration in Supplementary 
Materials S1).  
4.3. Implications  
Our results showed no relationship between the use of most substances and impaired 
response inhibition, except for a relationship between cannabis use and impaired inhibition, 
and in non-cannabis users an association between cigarette use and impaired inhibition. What 
are the theoretical implications? First, these findings could be of relevance for the current 
debate on the question whether addiction should be considered a chronic brain disease or not 
(Heather et al., 2017; Leshner, 1997; Field, 2015; Volkow, Koob, Mental, Parity, & Act, 
2015). The current findings do not support the idea that long-term recreational substance use 
leads to irreparable problems in inhibition, although it cannot be excluded that inhibition 
problems are present in (a subgroup of) people diagnosed with SUD. Second, in many dual 
process models of addiction, suboptimal inhibition of stimulus-driven appetitive processes 
(cue-reactivity) plays an important role in the escalation of use (e.g., Baler & Volkow, 2006; 
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Wiers et al., 2007). An alternative perspective does not emphasize the competition between 
stimulus-driven and goal-directed processes, but rather between different goal-directed 
processes (Moors, Boddez, & de Houwer, 2017). Individuals learn to mobilize and allocate 
resources strategically according to goal saliency and importance (Köpetz, Lejuez, Wiers, & 
Kruglanski, 2013). In this way, the inhibition capability of substance users is expected to 
fluctuate moment-to-moment (i.e., state-like) based on the external and internal context. Note 
again that the current findings do not exclude the possibility that in severe addiction(s), 
chronic inhibition problems of stimulus-driven processes do play a role. It merely 
underscores the goal-directed nature of (heavy) substance use. Third, impaired response 
inhibition as an immediate consequence of substance consumption may be more important 
than general inhibitory impairments in the long term. Compared with long-term (non-
dependent)substance use, acute use is more consistently related to impaired inhibitory control 
that enhances further consumption (Gan et al., 2014).  
4.4. Limitations and Suggestions for Future Study 
There are several limitations of the current study worth considering. First, the 
response rate was rather low. Although more than 100 studies met our inclusion and 
exclusion criteria, authors of only 65 studies provided raw data. The reasons for this include 
inaccessibility of the data, data could not be shared due to regulations, and a lack of success 
in contacting the authors. The low response rate is an obstacle encountered commonly in 
mega-analyses (Riley et al., 2010, 2007). We calculated and compared the effect sizes of 
studies that were included, studies that provided data but that were not included, and studies 
did not provide data. It was found that these three kinds of studies did not differ significantly 
on effect size (Fig. S4, see statistics in Supplementary Materials S9). In light of this, an open 
science framework is recommended in order to increase the transparency and availability of 
data for future research. Despite these obstacles, we received raw data from 3610 participants, 
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which should provide sufficient power to test effects on inhibition of substance use. Second, 
and relatedly, we noticed that the original studies did not score the use of every substance, for 
example, data on opiates were scarce. Although we tried to remedy this by means of multiple 
imputations, the analyses on the effects of these substances might have been underpowered. 
Third, except for alcohol and tobacco use, other substances could only be coded as a binary 
‘lifetime use’ variable. It would be optimal if a standard way of assessing all substances could 
be used in the future when assessing the relationship between substance use and inhibition (or 
other neuropsychological functions). Guidelines for experimental protocols and assessment of 
substance use would facilitate future multicenter comparisons, which could be stimulated by 
funding agencies requiring a standard assessment of all commonly used substances in a 
uniform format. Fourth, studies did not focus on poly-substance use. Studies recruited 
individuals taking one substance and recorded one/several other substances. Therefore, the 
samples are highly selective and not representative of poly-substance users. In addition, 
future studies are suggested to include a standard index of trait impulsivity (e.g., Eysenck’s 
personality inventory, Eysenck & Eysenck, 1965; BIS-11, Patton, Stanford, & Barratt, 1995) 
as it is possible that within-sample variability on this dimension is obscuring common effects 
of drug exposure, or has stand-alone effects, especially for stimulant users (Ersche et al., 
2012). Last, the effects of age and education years should be considered in the analysis and 
explanation of results. Task characteristics like stop trial percentage that consistently 
influence task performance should also be considered when comparing across studies.  
5. Conclusions  
The current mega-analysis aggregated raw data from 3610 participants in 43 studies on 
long-term (mostly) light to moderate substance use and response inhibition. The main finding 
is that limited evidence was found for impaired response inhibition in substance users, with 
two exceptions: lifetime cannabis use, and cigarette smoking in people who do not use 
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cannabis. The validity of these findings is underscored by expected findings for 
demographics (e.g., age, education level) and task characteristics (e.g., stop percentage). 
Broad assessment, standardized recording and reporting of substance use are highly needed in 
future studies. 
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Figure captions 
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Figure 1: PRISMA for the mega-analysis detailing our search and selection decisions. 
Figure 2: The interaction between cannabis and tobacco use on SSRT. Only for cannabis 
non-users, the more tobacco a person smoked on a daily basis, the longer his/her stopping 
latency. For cannabis users, a mild positive association was found between tobacco use and 
SSRT.  
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Table 1 
Description of included GNG studies (dependent variable is commission error rate)  
Study 
Demographic information 
    
substance of use Task characteristics Dependent variables   
Number of cases 
excluded 
(including the 
whole groups) 
Groups 
excluded Sample size 
(reserved) 
Age  Males Education years  Main substance 
in the original 
paper 
criteria for the 
heavy/problematic 
substance use 
group 
Other substance 
use info 
provided 
Trial number 
No-go 
percentage 
Substance 
Working 
memory load 
Task complexity Cue GNG 
No-go 
commission 
error 
Go RT  
Main behavioral 
findings 
M (SD) % M (SD) related M (SD) 
Ames et al, 
(2014) 
41 20.46 (1.27) 41 Missing Alcohol 
21 heavy drinker 
with AUDIT 
score>8, binge 
drink > 
twice/week and 
15 drinks (female 
8)/week 
  
200 20 Yes No Yes No 10 (6.22) 439(48) 
There was no 
difference 
between light 
and heavy 
drinker on 
commission 
error rate, and 
mean go RT 
  
 
 
Claus et al, 
(2013) 
144 32.64 (9.65) 69 14.2 (2.25) Alcohol 
81 participants 
were diagnosed 
with alcohol 
dependence 
according to 
DSM-5 
 
624 6.41 No Yes Yes No 59 (16.37) 335(59) 
There was no 
correlation 
between alcohol 
use disorder 
severity and 
inhibition 
performance 
 
 
 
Hendershot et 
al, (2015)
a
 
83 19.86 (0.81) 48 12.99 (1.34) Alcohol 
All participants at 
least binged drink 
once in the past 
month.  
Cannabis, 
cocaine 
62 20 No No No Yes 7 (7.8) 315(28) 
Response 
inhibition was 
worsened 
following the 
rising limb of 
blood alcohol 
concentration 
(BAC), which 
pattern 
increased during 
BAC plateau. 
Only baseline 
data (without 
alcohol intake) 
were used in the 
current study.  
 
 
 
Kamarajan et al, 
(2005) 
59 29.4 (7.14) 53 13.46 (2.89) Alcohol 
30 participants 
were alcoholic 
patients according 
to SDM-5  
Cannabis, 
cocaine, 
amphetamine, 
hallucinogens 
100 50 No No Yes No 5 (11.02) 297(20) 
There was no 
difference 
between 
alcoholics and 
controls in 
commission 
error rate and go 
RT 
1 
 
 59 
 
Kreusch et al, 
(2014) 
30 21.47 (3.01) 47 14.5 (2.37) Alcohol 
15 heavy drinkers 
with AUDIT >11 
 
100 25 No No No No 4 (4.55) 335(61) 
For the letter 
GNG task, 
heavy drinkers 
made more 
commission 
errors than light 
drinkers, while 
no difference on 
go RT.  
 
 
 
Littel et al, 
(2012) 
56 21.91 (4.17) 61 Missing Game 
25 excessive 
gamers had a 
Videogame 
Addiction Test 
(VAT) score>2.5 
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens 
636 11.6 No Yes Yes No 43 (19.08) 339(55) 
Excessive 
gamers made 
more 
commission 
errors than 
controls. 
26 
Excessive 
gamers 
López-Caneda 
et al, (2014) 
57 18.74 (0.55) 46 14 (0) Alcohol 
Binge drinkers 
binge drink at 
least once a week 
OR binge drink 
once a month with 
at least three 
drinks per hour 
for at least two 
years. 
Cannabis 150 50 No No Yes No 4 (4.06) 529(40) 
There was no 
difference 
between binge 
drinkers and 
controls in go 
RT and 
commission 
error rate. 
1 
 
Luijten et al, 
(2011) 
78 21.46 (2.05) 72 14.44 (1.13) Tobacco 
Smokers smoked 
at least 10 
cigarettes per day 
for at least two 
years. 
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens 
896 25 Yes No No No 30 (15.09) 261(32) 
Smokers made 
more 
commission 
errors than 
controls, while 
there was no 
correlation 
between daily 
cigarette 
consumption 
and commission 
error rate. And 
there was no 
group difference 
of go RT.  
 
 
 
Luijten, 
O’Connor et al, 
(2013) 
32 25.25 (5.21) 63 15.75 (2.2) Tobacco 
Smokers smoked 
at least 15 
cigarettes per day 
for at least two 
years. 
Cannabis, 
cocaine, 
amphetamine, 
hallucinogens 
160 12.5 No No Yes No 21 (13.94) 408(53) 
Smokers did not 
differ from 
controls in 
commission 
error rate and go 
RT. 
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Luijten, 
Veltman et al, 
(2013) 
48 22.17 (2.42) 67 14.89 (1.45) Tobacco 
Smokers smoked 
at least 15 
cigarettes per day 
for at least three 
years. 
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens 
927 11.86 No Yes Yes No 39 (14.49) 356(51) 
Smokers made 
more 
commission 
errors and also 
had longer go 
RT compared 
with non-
smokers 
 
 
 
Luijten et al, 
(2015) 
16 21.38 (3.03) 100 15.88 (1.02) Gamer  
Problem gamers 
scored more than 
2.5 on VAT.  
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens 
927 12 No Yes Yes No 43 (14.96) 409(42) 
Problem gamers 
made more 
commission 
errors than 
controls, while 
there was no 
group difference 
in go RT. 
18 
Excessive 
gamers 
Mahmood et al, 
(2013) 
36 18.64 (0.34) 72 14 (0) No specific 
High frequency 
substance users 
had any drug use 
over 180 
occasions. 
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens    
180 32 No No Yes No 14 (8.82) 
 There was no 
difference in 
commission 
error rate 
between high 
and low-
frequency 
substance users.  
44 
 
Petit et al, 
(2012) 
35 21.29 (1.98) 51 14 (0) Alcohol 
Heavy social 
drinkers had on 
average 20 drinks 
per week, and 
with AUDIT>11.  
 
798 30 Yes No No No 19 (7.67) 288(31) 
Heavy drinkers 
made more 
commission 
error than light 
drinkers when 
the background 
picture is 
alcohol-related.  
 
 
 
Paz et al, 
(2018)
b*
 
203 21.06 (1.87) 48 15.04 (1.1) No specific 
Binge drink was 
assessed with the 
last three items of 
alcohol use 
questionnaire 
(AUQ).  
Cannabis, 
cocaine, ecstasy 
256 12.5 No No No No 14 (10.15) 393(45) 
The correlation 
between the 
commission 
error rate and 
binge score was 
not reported.  
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Pike et al, 
(2015)
c
 
91 39.93 (8.28) 64 11.67 (1.91) Cocaine 
There was no 
control group and 
all participants 
reported cocaine 
use for the past 
month.  
Cannabis, 
amphetamine, 
hallucinogens 
125 20 Yes No Yes Yes 10 (12.13) 356(60) 
Cocaine users 
made more 
commission 
errors to a no-go 
target following 
a cocaine image 
as the go cue 
compared to a 
neutral image as 
a go cue; While 
the correlation 
between 
severity of use 
and inhibition 
performance 
was not 
reported.  
 
 
 
Quednow et al, 
(2007) 
51 24.29 (4.75) 100 12.69 (1.46) Ecstasy  
Ecstasy group 
used ecstasy 50 
times over a 
period of at least 1 
year. Cannabis 
group was chronic 
users of cannabis.  
Cannabis, 
cocaine, 
amphetamine, 
hallucinogens 
160 50 No Yes Yes No 25 (12.35) 1168(283) 
Ecstasy group 
made more 
commission 
errors than 
cannabis users 
who performed 
as well as the 
controls. 
Besides, across 
groups, 
commission 
error rate 
correlated with 
cumulative 
cannabis dose, 
years of 
amphetamine 
use, cocaine use 
per week, years 
of cocaine use 
and the 
cumulative 
cocaine dose.  
6 
 
Rass et al, 
(2014) 
82 25.29 (5.36) 48 15.82 (1.91) Tobacco 
Daily smokers 
smoked<25 
cigarettes per day, 
daily use for at 
least 1 year, and 
scored ≥4 on the 
FTND.  
Cannabis, 
cocaine, 
amphetamine 
500 20 No No No No 25 (12.25) 239(43) 
Smokers and 
controls did not 
differ in 
commission 
error rate and go 
RT 
 
 
 
Roberts et al, 
(2010) 
39 22.38 (2.93) 51 16.44 (2.45) 
Ecstasy & 
cannabis 
Ecstasy group 
were current 
ecstasy users and 
consumed at least 
40 ecstasy tablets 
over a period of a 
year. 
cocaine, 
amphetamine 
500 10 No Yes Yes No 45 (17.51) 316(42) 
Ecstasy users 
did not differ 
from controls in 
commission 
error rate and go 
RT. 
1 
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Roberts et al, 
(2013) 
59 23.26 (2.99) 44 Missing Ecstasy & poly 
Ecstasy group 
needs to take 
ecstasy for at least 
five occasions.  
Cannabis, 
cocaine 
240 25 No No Yes No 6 (5.78) 363(61) 
Ecstasy 
polysubstance 
users, non-
ecstasy 
polysubstance 
users, and 
controls did not 
differ in 
commission 
error rate and go 
RT. 
1 
 
Rossiter et al, 
(2012) 
124 26.43 (6.79) 48 15.47 (2.48) Alcohol 
The harmful 
alcohol use group 
had an AUDIT 
score no less than 
16.  
 
160 12.5 No Yes Yes No 37 (17.25) 338(55) 
Harmful alcohol 
use group made 
fewer 
commission 
errors compared 
with controls 
under the 
delayed reward 
condition; The 
opposite pattern 
was observed 
under the 
immediate 
punishment 
condition. And 
there was no 
difference with 
regards to go 
RT. 
 
 
 
Takagi et al, 
(2011, 2014) 
30 20.49 (1.48) 43 10.73 (1.51) 
Inhalant & 
cannabis 
Inhalant users had 
inhalants daily or 
almost daily use 
for more than 12 
months.  
cocaine, 
amphetamine, 
ecstasy 
300 10 No No No No 22 (15.8) 332(48) 
[ref 2011] 
Inhalant users 
and controls did 
not differ in 
commission 
error rate and go 
RT; [ref 2014] 
The inhalant 
group had lower 
d-prime score 
compared with 
controls.  
44 Inhalant 
Verdejo-García 
et al, (2012) 
19 28.68 (7.92) 58 12.26 (1.19) Opiate 
Opiate dependents 
had an average 
score on SDS 
(Severity of 
Dependence 
Scale) of 8.3. 
Cannabis, 
cocaine, 
amphetamine, 
ecstasy, 
hallucinogens 
300 23.33 No No No No 17 (9.08) 315(36) 
Controls made 
more 
commission 
errors compared 
with opiate 
dependents.  
38 Opiate 
Wetherill et al, 
(2013) 
18 19.49 (0.99) 33 12.89 (1.32) Alcohol 
Heavy drinkers at 
least had 4 drinks 
per occasion, less 
than once per 
month but more 
than once per 
year.  
Cannabis 180 32 No No Yes No 9 (6.79) 514(62) 
Heavy drinkers 
and controls did 
not differ in 
commission 
error rate.  
22 
  
 63 
 
 
Note: go RT = correct go trials reaction time; M = mean; SD = standard deviation.  
*Unpublished dataset at time of searching literature 
Why comparison between substance users and controls could not be obtained from the original paper  
a interested in the difference between the increasing and decreasing limb of BAC but we only used baseline data when participants were sober 
b the correlation between commission error rate and binge score was not reported 
c focused on the experimental effect (different kinds of cued GNG) instead of the individual difference 
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Table 2  
Description of included SST studies (dependent variable is SSRT) 
Study 
Demographic information 
    
substance of use Task parameters 
      
Dependent variables   
Number of cases 
excluded 
(including the 
whole groups) 
Groups 
excluded Sample size 
(reserved) 
Age  Male Education years  Main substance 
in the original 
paper 
criteria for the 
heavy/problematic 
substance use 
group 
Other substance 
use info 
provided  
Trial number 
No-go 
percentage % 
Stop signal 
modality 
SSD 
SSRT SSRT Go RT  
Main behavioral 
findings 
M (SD)  % M (SD) computation M (SD) M (SD) 
Bidwell et al. 
(2013)
a
 
150 21.56 (3.16) 64 Missing Cannabis 
All participants 
used marijuana at 
least once a week 
in the past 
month and at least 
10 times in the 
past 6 months. 
 
192 25 Auditory Staircase Other 274(66) 576(183) 
There was no 
correlation 
between SSRT 
and BIS-11.  
1 
 
Bø et al. (2016) 119 21.71 (2.12) 5 14.95 (1.56) Alcohol 
All participants 
use alcohol on a 
regular basis, 
binge score was 
calculated based 
on the last three 
items of the 
Alcohol 
Use 
Questionnaire. 
 
320 25 Auditory Staircase Other 189(54) 357(76) 
Binge score was 
not a significant 
predictor of 
SSRT 
2 
 
Bø et al. 
(2017)* 
186 36.22 (12.8) 32 16.45(2.7) Depression 
No special 
requirement for 
substance use 
Cannabis, 
cocaine 
320 25 Auditory Staircase Other 187(50) 413(123) 
Weekly alcohol 
consumption 
negatively 
correlated with 
SSRT. 
120 
Major 
depressive 
disorder  
Colzato et al. 
(2007) 
24 29.33 83 Missing Cocaine 
Recreational 
cocaine users 
should consume 
cocaine 1 to 4 
gram per month 
by snorting route 
for a minimum of 
two years.  
 
520 30 Visual Staircase Integration 215(27) 375(39) 
SSRT was 
significantly 
longer for 
cocaine users 
than non-users.  
 
 
Courtney et al. 
(2012, 2013)
b
  
304 37.15 (10.81) 7 13.29 (3.25) Alcohol 
All participants 
were problem 
drinkers, with a 
minimum of 48 
standard drinks 
per month. 
 
64 25 Auditory Staircase Other 241(90) 525(96) 
Response 
inhibition 
(SSRT) could 
not explain 
alcohol use and 
alcohol 
problems.  
6 
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de Ruiter et al. 
(2012) 
35 34.2 (9.25) 1 11.86 (1.67) 
Gambling & 
Tobacco 
Problem gamblers 
were diagnosed 
by SDM-5. Heavy 
smokers smoked 
at least 15 
cigarettes per day.  
 
360 32 Visual Staircase Other 270(46) 435(87) 
Problem 
gamblers, heavy 
smokers, and 
controls did not 
differ in SSRT 
and go RT 
17 Gambling 
 
Filbey et al. 
(2013) 
74 24.14 (7.2) 74 13.5(2.68) Cannabis 
All participants 
were cannabis 
users with at least 
4 uses per week 
for at least 6 
months prior. 
Among them, 44 
were diagnosed 
with cannabis 
dependents 
according to 
SDM-5.  
cocaine, ecstasy 384 25 Auditory Staircase Integration 190(44) 512(76) 
Cannabis 
dependents and 
cannabis non-
dependents did 
not differ in 
SSRT and go 
RT.  
 
 
 
Fillmore et al. 
(2002) 
44 40.27 (6.66) 61 12.18(1.4) Cocaine 
Participants in the 
cocaine use group 
need to score ≥4 
on the Drug and 
Abuse Screening 
Test (DAST), 
habitual cocaine 
use for a 
minimum of 6 
month and past 
week cocaine use. 
 
176 27 Auditory Fixed Integration 318(91) Missing 
Cocaine users 
showed 
prolonged SSRT 
compared with 
controls, while 
go RT was 
comparable.  
  
Galván et al. 
(2011) 
59 19.49 (1.1) 61 13.75 (1.17) Tobacco 
Daily smokers 
should smoke 
daily for at least 6 
months.  
 
256 25 Auditory Staircase Integration 164(61) 479(90) 
Smokers did not 
differ from 
controls in 
SSRT and go 
RT 
74 
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Glass et al. 
(2009) 
495 44.1 (4.97) 47 13.9(2.27) 
Alcohol & 
Tobacco 
A self-developed 
variable of 
alcohol severity 
was used, with 65 
participants 
categorized as 
alcohol abuse, 55 
as alcohol 
dependence 
without physical 
dependence, 33 as 
alcohol 
dependence with 
physical 
dependence.  
Cannabis, 
cocaine 
256 25 Auditory Staircase Other 250(76) 839(202) 
Both SSRT and 
go RT had a 
significant 
negative 
correlation with 
alcoholism 
severity.  
77 
 
Karoly et al. 
(2014)
b
 
53 28.3 (6.91) 47 15.55 (1.85) Alcohol 
All participants 
were categorized 
as heavy drinkers 
with at least two 
drinks (three for 
men) twice per 
week. Among 
them, twelve 
participants were 
with AUDIT 
score ≥16.  
Cannabis 198 26 Auditory Staircase Integration 172(48) 568(108) 
The relationship 
between 
SSRT/go RT 
and alcohol use 
was not reported 
in the paper.  
 
 
Kräplin et al. 
(2015) 
75 26 (7.92) 39 11.74 (0.76) 
Gambling & 
Tobacco 
Pathological 
gambling (PG) 
and nicotine 
dependence (ND) 
were dragonized 
with DSM-5. 
Cannabis 205 20 Visual Staircase Integration 298(93) 557(159) 
PG lead to 
prolonged SSRT 
compared with 
controls. There 
is no difference 
between PG and 
ND; ND and PG 
comorbid ND 
with regard to 
SSRT.  
44 
Gambling 
disorder 
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Moallem et al. 
(2012)  
287 30.97 (10.61) 73 14.68 (2.59) 
Alcohol & 
Tobacco 
Smokers should 
smoke cigarettes 
no less than 10 
per day and had 
less than 3 
months' smoking 
abstinence in the 
past year. Heavy 
drinkers were 
defined by 
National Institute 
on Alcohol Abuse 
and Alcoholism 
(NIAAA), i.e. 
drinks per 
week >14  
(women > 7) or 
drinks per 
occasion ≥ 5 (≥ 4 
for women) at 
least once per 
month over the 
past year.  
 
64 25 Auditory Staircase Other 223(88) 509(90) 
Heavy drinkers, 
smokers, heavy 
drink smokers 
did not differ in 
SSRT and go 
RT; After 
controlling for 
age, heavy 
drinker smokers 
showed slower 
go RT compared 
with smokers.  
11 
 
 
Papachristou et 
al. (2012a)
c
 
42 25.5 (9.66) 24 Missing Alcohol 
All participants 
were light to 
moderate social 
drinkers with an 
average AUDIT 
score of 7.7.  
 
256 25 Auditory Staircase Other 222(50) 344(63) 
The relationship 
between AUDIT 
and SSRT was 
not reported.  
 
 
Papachristou et 
al. (2012b) 
75 23.29 (5.2) 33 Missing Alcohol 
Heavy and light 
social drinkers 
were classified by 
the cut-off score 
of 11 of AUDIT.  
 
256 25 Auditory Staircase Other 203(32) Missing 
Light and heavy 
drinkers had 
similar SSRT.  
  
Paz et al. 
(2018)
d*
 
182 21.15 (1.83) 49 15.1(1.08) Not specific 
Binge drink was 
assessed with the 
last three items of 
alcohol use 
questionnaire 
(AUQ).  
Cannabis, 
cocaine, ecstasy 
256 25 Auditory Staircase Integration 227(47) 694(175) 
The relationship 
between SSRT 
and binge score 
was not 
reported.  
21 
 
Tsaur et al. 
(2015)
e
 
21 34.73 (12.47) 76 13.9(1.18) Tobacco 
All participants 
were smokers 
with at least 10 
cigarettes per day 
for the past year.  
 
192 25 Auditory Staircase Other 252(52) 560(112) 
Only baseline 
data was used. 
The correlation 
between daily 
cigarette 
smoking and 
SSRT was not 
reported.  
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Vonmoos et al. 
(2013) 
163 30.03 (8.18) 71 10.45 (1.74) Cocaine 
Cocaine 
dependence was 
diagnosed with 
DSM-IV. All 
cocaine users 
should have 
cocaine as the 
primary used 
illegal drug, 
cocaine use 
of >0.5 g per 
month, and 
abstinence 
duration of <6 
months.  
Cannabis, 
ecstasy, 
amphetamine 
192 25 Auditory Staircase Integration 291(63) 745(192) 
Two cocaine use 
group 
(recreational 
users and 
dependent users) 
and the control 
group had 
similar SSRT 
and go RT. 
3 
 
Zack et al. 
(2015) 
12 33.75 (11.23) 1 15.92 (0.52) Gambling 
Pathological 
gambling (PG) 
was diagnosed 
with SDM-5 and a 
score ≥5 on 
the SOGS (South 
Oaks Gambling 
Screen). 
Cannabis 512 25 Auditory Staircase Other 182(27) 482(115) 
There was no 
difference 
between PG and 
healthy controls 
with regard to 
go RT and 
SSRT.  
13 Gambling 
Note: DV: dependent variable; SSD = stop-signal delay; SSRT = stop-signal reaction time; go RT = correct go trials reaction time; M = mean; SD = standard deviation.  
*Unpublished dataset at time of searching literature 
Why comparison between substance users and controls could not be obtained from the original paper 
a did regression analysis 
b only reported MRI results 
c focused on experimental effect rather than individual difference with a within-subject design 
d 
the correlation between commission error rate and binge score was not reported 
e longitudinal study along substance abstinence, only baseline data were used 
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Table 3a 
Quality assessment scores of included GNG studies according to the NHLBI Quality Assessment Tool  
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 
Quality 
Rating  
Ames et al, (2014) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Claus et al, (2013) yes yes NR yes no no no yes yes no yes NR NA yes good 
Hendershot et al, (2015) yes yes NR yes no yes yes yes yes yes yes NR NA yes fair 
Kamarajan et al, (2005) yes yes NR no no no no no yes no yes NR NA yes fair 
Kreusch et al, (2014) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Littel et al, (2012) yes yes NR yes no no no yes yes no yes NR NA yes fair 
López-Caneda et al, (2014) yes yes NR yes no yes yes yes yes yes yes NR NA yes good 
Luijten et al, (2011) yes yes NR yes no no no no yes no yes NR NA yes fair 
Luijten, O’Connor et al, (2013) yes no NR CD yes no no no yes no yes NR NA yes fair 
Luijten, Veltman et al, (2013) yes yes NR CD no no  no no yes no yes NR NA yes fair 
Luijten et al, (2015) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Mahmood et al, (2013) yes yes NR yes no yes yes yes yes yes yes NR NA yes good 
Petit et al, (2012) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Paz et al, (2018) yes yes NR yes no yes yes yes yes yes yes NR NA no fair 
Pike et al, (2015) 
yes yes NR yes yes no no no yes no yes NR NA yes fair 
Quednow et al, (2007) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Rass et al, (2014) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Roberts et al, (2010) yes no NR yes no no no no yes no yes NR NA yes fair 
Roberts et al, (2013) yes no NR yes no no no no yes no yes NR NA yes suboptimal 
Rossiter et al, (2012) yes yes NR yes no no no yes yes no yes NR NA yes good 
Takagi et al, (2011) yes yes NR yes yes no no yes yes no yes NR NA yes fair 
Takagi et al, (2014) yes yes NR yes yes no no yes yes no yes NR NA no fair 
Verdejo-García et al, (2012) yes yes NR yes yes yes yes yes yes no yes NR NA yes good 
Wetherill et al, (2013) yes yes NR yes no yes yes no yes no yes NR yes yes good 
 
               
Note: CD: cannot determine; NA: not applicable; NR: not reported; Meanings of criteria Q1-Q14 can be found in Table S2.                
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Table 3b 
Quality assessment scores of included SST studies according to the NHLBI Quality Assessment Tool  
               
 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 
Quality 
Rating 
Bidwell et al. (2013) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Bø et al. (2016) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Bø et al. (2017) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Colzato et al. (2007) yes yes NR yes no no no no yes no yes NR NA yes fair 
Courtney et al. (2012) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Courtney et al. (2013) yes yes NR yes yes no no yes yes no yes NR NA yes good 
de Ruiter et al. (2012) yes yes NR no no no no yes yes no yes NR NA yes fair 
Filbey et al. (2013) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Fillmore et al. (2002) yes yes NR yes no no no no yes no yes yes NA yes fair 
Galván et al. (2011) yes yes NR yes no no no no yes no yes NR NA yes fair 
Glass et al. (2009) yes no NR no no yes yes yes yes no yes yes NA yes good 
Karoly et al. (2014) yes yes NR yes no no no yes yes no yes NR NA no fair 
Kräplin et al. (2015) yes yes NR yes yes no no yes yes no yes NR NA yes good 
Moallem et al. (2012)  yes yes NR yes yes no no yes yes no yes NR NA yes good 
Papachristou et al. (2012a) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Papachristou et al. (2012b) yes yes NR yes no no no yes yes no yes NR NA yes fair 
Paz et al, (2018) yes yes NR yes no yes yes yes yes yes yes NR NA no fair 
Tsaur et al. (2015) yes yes NR yes yes no CD yes yes no yes NR yes yes fair 
Vonmoos et al. (2013) yes yes NR yes yes yes CD yes yes no yes NR NA yes good 
Zack et al. (2015) yes yes NR yes yes no no no yes no yes NR NA yes fair 
 
Note: CD: cannot determine; NA: not applicable; NR: not reported; Meanings of criteria Q1-Q14 can be found in Table S2. 
 
               
                
 
               
                
                
 
